Severe myocarditis as a cause of the formation of cardiorenal syndrome in a patient with refractory rheumatoid arthritis
https://doi.org/10.47360/1995-4484-2022-495-500
Abstract
According to modern concepts, myocarditis is an inflammatory disease of the myocardium, diagnosed on the basis of generally accepted histological, immunological, immunohistochemical criteria. Previously, most researchers believed that the most common cardiac extra-articular manifestation of rheumatoid arthritis (RA) is pericarditis. In the last decade, using magnetic resonance imaging (MRI) of the heart, it turned out that myocarditis in patients with rheumatoid arthritis is not a rare manifestation of the disease. Recently, there is increasing evidence that inflammatory cytokines in RA can also directly cause chronic myocardial damage, further contributing to the development of chronic heart failure (CHF). In our clinical case, myocarditis developed in a patient with active refractory rheumatoid arthritis. The myocardial lesion in the patient was characterized by pronounced echocardiographic signs of restrictive cardiomyopathy, a significant decrease in the ejection fraction with the development of heart failure, various rhythm disturbances in combination with acute renal dysfunction, which led to the formation of cardiorenal syndrome (CRS). Complete regression of myocarditis and cattle occurred precisely against the background of effective treatment of refractory rheumatoid arthritis (RA) with basic antirheumatic drugs and the successful use of biological therapy.
About the Authors
Z. Yu. MutovinaRussian Federation
121359, Moscow, Marshala Timoshenko str., 19, building 1A;
123182, Moscow, Pekhotnaya str., 3
A. V. Gordeev
Russian Federation
121359, Moscow, Marshala Timoshenko str., 19, building 1A;
115522, Moscow, Kashirskoye Highway, 34A
I. V. Rozanova
Russian Federation
121356, Moscow, Marshala Timoshenko str., 15
E. A. Galushko
Russian Federation
115522, Moscow, Kashirskoye Highway, 34A
References
1. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, et al. Report of the 1995 World Health Organization/ International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation. 1996;93(5):841-842. doi: 10.1161/01.cir.93.5.841
2. Nasonov EL. Achievements in rheumatology in the XXI century. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014; 52(2):133-140 (In Russ.). doi: 10.14412/1995-4484-2014-133-140
3. Caforio AL, Pankuweit S, Arbustini E, Basso C, GimenoBlanes J, Felix SB, et al.; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-2648, 2648a-2648d. doi: 10.1093/eurheartj/eht210
4. Nemchinov EN, Krel AA. Rheumatoid heart disease. Terapevticheskiy arkhiv. 1986;12:126-134 (In Russ.).
5. Turesson C, Jacobsson L, Bergström U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford). 1999;38(7):668-674. doi: 10.1093/rheumatology/38.7.668
6. Kobayashi Y, Giles JT, Hirano M, Yokoe I, Nakajima Y, Bathon JM, et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: A pilot study. Arthritis Res Ther. 2010;12(5): R171. doi: 10.1186/ar3131
7. Mavrogeni S, Bratis K, Sfendouraki E, Papadopoulou E, Kolovou G. Myopericarditis, as the first sign of rheumatoid arthritis relapse, evaluated by cardiac magnetic resonance. Inflamm Allergy Drug Targets. 2013;12(3):206-211. doi: 10.2174/1871528111312030008
8. Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, et al. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: Insights from CMR T1 mapping. JACC Cardiovasc Imaging. 2015;8(5):526-536. doi: 10.1016/j.jcmg.2014.12.025
9. Puntmann VO, Taylor PC, Barr A, Schnackenburg B, Jahnke C, Paetsch I. Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: A magnetic resonance imaging study. Rheumatology (Oxford). 2010;49(3):528-535. doi: 10.1093/rheumatology/kep426
10. Bradham WS, Bozkurt B, Gunasinghe H, Mann D, Spinale FG. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: A current perspective. Cardiovasc Res. 2002;53(4):822-830. doi: 10.1016/s0008-6363(01)00503-x
11. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000;102(16):1944- 1949. doi: 10.1161/01.cir.102.16.1944
12. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. ATTRACT Study Group. Lancet. 1999;354(9194): 1932-1939. doi: 10.1016/s0140-6736(99)05246-0
13. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527-1539. doi: 10.1016/j.jacc.2008.07.051
14. Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006;17(10):2886-2891. doi: 10.1681/ASN.2006010063
15. Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B; POSH Investigators. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: Results of the prospective outcomes study in heart failure (POSH). Eur Heart J. 2006;27(10):1216-1222. doi: 10.1093/eurheartj/ehi859
16. Ronco C. Cardiorenal and renocardiac syndromes: Clinical disorders in search of a systematic definition. Int J Artif Organs. 2008;31(1):1-2. doi: 10.1177/039139880803100101
17. Gordeev AV, Galushko EA, Nasonov EL. The concept of multimorbidity in rheumatologic practice. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014;52(4):362-365 (In Russ.). doi: 10.14412/1995-4484-2014-362-365
18. Mutovina ZYu, Zagrebneva AI, Galushko EA, Gordeev AV. Cardiorenal syndrome in patients with rheumatoid arthritis. Modern Rheumatology Journal. 2019;13(3):82-86 (In Russ.). doi: 10/14412/1996-7012-2019-3-82-86
Review
For citations:
Mutovina Z.Yu., Gordeev A.V., Rozanova I.V., Galushko E.A. Severe myocarditis as a cause of the formation of cardiorenal syndrome in a patient with refractory rheumatoid arthritis. Rheumatology Science and Practice. 2022;60(4):495-500. (In Russ.) https://doi.org/10.47360/1995-4484-2022-495-500